6
Registered trials
3
Recruiting
6
Unique sponsors
4
Unique IMPs
4
Commercial trials
Drug classes (ATC)
—
ATC code not specified
4
N
Neurology/Psychiatry (ATC N)
2
Mechanism of action (INN-stem analysis)
Unknown / small molecule
4 substances
Phase III:
1
Phase II:
2
Phase I (Other):
3
Phase III
1 trial-
EndedUCB Biopharma CommercialLACOSAMIDE
Phase II
2 trials-
RecruitingEisai Limited CommercialPERAMPANEL
-
RecruitingAzienda Ospedaliera Universitaria Meyer IRCCS AcademicCANNABIDIOL
Phase I (Other)
3 trials-
RecruitingQuralis Corp. CommercialIMP not specified
-
EndedRapport Therapeutics Inc. CommercialIMP not specified
-
EndedTrevena Inc. AcademicTRV045
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Quralis Corp. | Commercial | 1 | Phase I (Other) | 1 |
| Rapport Therapeutics Inc. | Commercial | 1 | Phase I (Other) | 0 |
| Eisai Limited | Commercial | 1 | Phase II | 1 |
| UCB Biopharma | Commercial | 1 | Phase III | 0 |
| Trevena Inc. | Academic | 1 | Phase I (Other) | 0 |
| Azienda Ospedaliera Universitaria Meyer IRCCS | Academic | 1 | Phase II | 1 |
New trials by year
2019
1
2020
1
2023
1
2024
2
2026
1